The ESMO magnitude of clinical benefit scaling tool: from theory to practice (English)
- New search for: Hartmann, M.
- New search for: Hartmann, M.
In:
ANNALS OF ONCOLOGY
;
26
, 11
;
2357-2358
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:The ESMO magnitude of clinical benefit scaling tool: from theory to practice
-
Contributors:Hartmann, M. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 26, 11 ; 2357-2358
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2015-01-01
-
Size:2 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 26, Issue 11
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2203
-
Is chemotherapy still an option in the treatment of melanoma?Carlino, M. S. / Long, G. V. et al. | 2015
- 2205
-
Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysisIbrahim, M. F. / Mazzarello, S. / Shorr, R. / Vandermeer, L. / Jacobs, C. / Hilton, J. / Hutton, B. / Clemons, M. et al. | 2015
- 2213
-
Why has active immunotherapy not worked in lung cancer?Thomas, A. / Giaccone, G. et al. | 2015
- 2221
-
Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer—going beyond PSA and imaging, a systematic literature reviewSchmid, S. / Omlin, A. / Blum, D. / Strasser, F. / Gillessen, S. / Rothermundt, C. et al. | 2015
- 2247
-
Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factorsDimopoulos, M. A. / Sonneveld, P. / Siegel, D. / Palumbo, A. / San-Miguel, J. et al. | 2015
- 2257
-
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studiesGenkinger, J. M. / Kitahara, C. M. / Bernstein, L. / Berrington de Gonzalez, A. / Brotzman, M. / Elena, J. W. / Giles, G. G. / Hartge, P. / Singh, P. N. / Stolzenberg-Solomon, R. Z. et al. | 2015
- 2267
-
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanomaHersh, E. M. / Del Vecchio, M. / Brown, M. P. / Kefford, R. / Loquai, C. / Testori, A. / Bhatia, S. / Gutzmer, R. / Conry, R. / Haydon, A. et al. | 2015
- 2274
-
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502Sadahiro, S. / Tsuchiya, T. / Sasaki, K. / Kondo, K. / Katsumata, K. / Nishimura, G. / Kakeji, Y. / Baba, H. / Sato, S. / Koda, K. et al. | 2015
- 2280
-
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialDavidson, A. / Veillard, A. S. / Tognela, A. / Chan, M. M. / Hughes, B. G. / Boyer, M. / Briscoe, K. / Begbie, S. / Abdi, E. / Crombie, C. et al. | 2015
- 2286
-
A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†Dingemans, A. M. / Groen, H. J. / Herder, G. J. / Stigt, J. A. / Smit, E. F. / Bahce, I. / Burgers, J. A. / van den Borne, B. E. / Biesma, B. / Vincent, A. et al. | 2015
- 2293
-
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriersCastro, E. / Jugurnauth-Little, S. / Karlsson, Q. / Al-Shahrour, F. / Piñeiro-Yañez, E. / Van de Poll, F. / Leongamornlert, D. / Dadaev, T. / Govindasami, K. / Guy, M. et al. | 2015
- 2300
-
RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trialLee, J. L. / Kim, M. K. / Park, I. / Ahn, J. H. / Lee, D. H. / Ryoo, H. M. / Song, C. / Hong, B. / Hong, J. H. / Ahn, H. et al. | 2015
- 2305
-
Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivorsBoer, H. / Proost, J. H. / Nuver, J. / Bunskoek, S. / Gietema, J. Q. / Geubels, B. M. / Altena, R. / Zwart, N. / Oosting, S. F. / Vonk, J. M. et al. | 2015
- 2311
-
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†Casulo, C. / Day, B. / Dawson, K. L. / Zhou, X. / Flowers, C. R. / Farber, C. M. / Hainsworth, J. D. / Cerhan, J. R. / Link, B. K. / Zelenetz, A. D. et al. | 2015
- 2317
-
Life expectancy of young adults with follicular lymphomaConconi, A. / Lobetti-Bodoni, C. / Montoto, S. / Lopez-Guillermo, A. / Coutinho, R. / Matthews, J. / Franceschetti, S. / Bertoni, F. / Moccia, A. / Rancoita, P. M. et al. | 2015
- 2323
-
Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphomaGraf, S. A. / Stevenson, P. A. / Holmberg, L. A. / Till, B. G. / Press, O. W. / Chauncey, T. R. / Smith, S. D. / Philip, M. / Orozco, J. J. / Shustov, A. R. et al. | 2015
- 2329
-
Histologic transformation in marginal zone lymphomas†Conconi, A. / Franceschetti, S. / Aprile von Hohenstaufen, K. / Margiotta-Casaluci, G. / Stathis, A. / Moccia, A. A. / Bertoni, F. / Ramponi, A. / Mazzucchelli, L. / Cavalli, F. et al. | 2015
- 2335
-
Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutritionBozzetti, F. / Cotogni, P. / Lo Vullo, S. / Pironi, L. / Giardiello, D. / Mariani, L. et al. | 2015
- 2341
-
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumorsde Braud, F. / Cascinu, S. / Spitaleri, G. / Pilz, K. / Clementi, L. / Liu, D. / Sikken, P. / De Pas, T. et al. | 2015
- 2347
-
Oncology 2020: a drug development and approval paradigmDhingra, K. et al. | 2015
- 2351
-
Evaluation of tumor-infiltrating lymphocytes in breast cancer; proposal of a simpler methodHida, A. I. / Ohi, Y. et al. | 2015
- 2352
-
New life for retrospective study in the precision oncology eraOrlandi, A. / Basso, M. / Calegari, M. A. / Barone, C. et al. | 2015
- 2352
-
Adjuvant chemotherapy after preoperative chemoradiotherapy for rectal cancerKanyilmaz, G. / Koc, M. / Aktan, M. et al. | 2015
- 2353
-
Reply to the letter to the editor ‘New life for retrospective study in the Precision Oncology Era’ by Orlandi et al.Pietrantonio, F. / Cremolini, C. et al. | 2015
- 2354
-
Management of advanced prostate cancervon Eyben, F. / Kiljunen, T. / Kangasmaki, A. / Kairemo, K. / von Eyben, R. / Joensuu, T. et al. | 2015
- 2354
-
Reply to the letter to the editor ‘Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015’ by Gillessen et al.Gillessen, S. / Fanti, S. / Omlin, A. et al. | 2015
- 2355
-
Hemorrhagic cystitis in a patient without a past history of radiation therapy who was treated with cabazitaxel for CRPCKosaka, T. / Oya, M. et al. | 2015
- 2356
-
Era-by-era improvement in survival for elderly patients with Hodgkin lymphoma; outcome data from a large population-based cohortBishton, M. J. / Hubbard, R. / Witherall, R. / Jones, S. G. / Richardson, F. / James, E. J. / Sovani, V. / Bessell, E. M. / Haynes, A. P. / McMillan, A. K. et al. | 2015
- 2357
-
The ESMO magnitude of clinical benefit scaling tool: from theory to practiceHartmann, M. et al. | 2015
- 2359
-
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumoursLévy, C. / Allouache, D. / Lacroix, J. / Dugué, A. E. / Supiot, S. / Campone, M. / Mahe, M. / Kichou, S. / Leheurteur, M. / Hanzen, C. et al. | 2015